FOXNews.com: FDA approves drug for rare leukemia

FOXNews.com FOX News Network - We Report. You Decide. // via fulltextrssfeed.com

FDA approves drug for rare leukemia Aug 10th 2012, 11:40 The Food and Drug Administration said it has approved Talon Therapeutics Inc's Marqibo treatment for adults with a rare form of leukemia known as Philadelphia chromosome negative acute lymphoblastic leukemia. The drug, a targeted version of generic chemotherapy drug vincristine, will be the first commercial product for Talon. The company is majority-owned by Warburg Pincus and Deerfield Management, but shares accounting for a minority portion of its equity trade over-the-counter and were down 5 percent in afternoon trading. Talon licensed Marqibo in 2006 after the FDA turned down an application for the drug, filed by two other companies, as a treatment for relapsed non-Hodgkin's lymphoma. Thursday's FDA approval is for acute lymphoblastic leukemia patients who have failed at least two other therapies. Talon's shares, which were down 5 percent at 92 cents, have more than doubled so far this year.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions